期刊文献+

肺腺鳞癌淋巴结转移规律的探讨 被引量:5

The rule of lymph node metastasis of adenosquamous carcinoma of the lung
原文传递
导出
摘要 目的分析肺腺鳞癌淋巴结转移(LNM)的特点。方法对361例肺腺鳞癌患者的临床资料进行回顾性分析。淋巴结分区和TNM分期采用国际抗癌联盟(UICC)标准(1997年)。统计分析采用,检验、Logrank检验和Cox比例风险模型分析。结果361例肺腺鳞癌纵隔LNM途径表现为:左肺上叶癌首先转移到主.肺动脉窗淋巴结,右肺上叶癌首先转移到下气管旁淋巴结,两侧下叶肺癌首先转移到隆突下淋巴结,右肺中叶肺癌以向上转移为主。纵隔淋巴结跳跃转移以隆突下最为多见,其次为主-肺动脉窗和下段气管旁。发生单一站纵隔淋巴结跳跃转移的患者预后好于其他LNM者。结论不同部位肺腺鳞癌的LNM途径和跳跃转移部位有所不同,治疗时应加以考虑。不同转移模式的患者预后不同,发生单一站纵隔淋巴结跳跃转移的患者预后可能较好。 Objective To investigate the rule of lymph node metastasis of adenosquamous carcinoma of the lung. Methods The data of 361 surgically treated patients with adenosquamous carcinoma of the lung from October 1965 to June 2003 were collected and retrospectively reviewed. The classification of regional lymph node stations and TNM stage were determined according to the UICC criteria ( 1997 ). The route and patterns as well as influencing factors of lymph node metastasis were analyzed by SPSS 10. 0 software. The median follow-up period was 5.5 years ( range, 1.4 to 23.4 years). Results The analysis of the route of mediastinal lymph node metastasis in the 361 cases showed that the tumor originated in the left upper lobe firstly metastasized to station 5 ( A-P window), tumor in the right upper lobe to the station 4 (lower paratracheal), then secondly to station 7 (subearinal), lastly to station 3 from the tumor in the left upper lobe or to the station 2 from the tumor in the right upper lobe. It was found that the tumors originated from the lower lobe, firstly metastasized to station 7, secondly to station 9 or 4 from the right lobe ; or station 5 from left lower lobe, lastly to station 3 or 2 in the mediastinum. For the tumor in the middle lobe, mainly metastasized to station 7, 4 and 2. The skip mediastinal lymph node metastasis but N1 negative most commonly metastasized to station 7, then to station 4 from the tumor in the right lung and 5 from the tumor in the left lung. The prognosis of patients with a single skipping metastasis to mediastinal lymph node ( NI-, SMLN) was better than that in the other patients with mediastinal lymph node metastases. Conclusion The lung cancer growing in a different location has a different route and skipping metastasis to mediastina] lymph nodes. The patterns of lymph node metastasis affect prognosis. The prognosis of patients with single skipping metastasis to mediastinal lymph nodes but negative pulmonary hilar lymph node is better than that in the other patients with multiple station mediastinal lymph node metastases. The "NI-, SMLN" pattern ought to be considered as a special lymph nodal metastasis with better prognosis.
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2009年第7期524-527,共4页 Chinese Journal of Oncology
关键词 肺肿瘤 肿瘤转移 淋巴结 Lung neoplasms Neoplasm metastasis Lymph nodes
  • 相关文献

参考文献10

  • 1Nakagawa K, Yasumitu T, Fukuhara K, et al. Poor prognosis after lung resection for patients with adenosquamous carcinoma of the lung. Ann Thorac Surg, 2003, 75:1740-1744.
  • 2Pelletier MP, Edwardes MD, Michel RP, et al. Prognostic markers in resectable non-small cell lung cancer: a multivariate analysis. Can J Surg, 2001,44:180-188.
  • 3Ohawada H. Histological classification of lung cancer ( Japan Lung Cancer Society). Nippon Rinsho, 2002, 60 Suppl 5:132-137.
  • 4Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging. Chest, 1997, 111 : 1710-1723.
  • 5Kotoulas CS, Foroulis CN, Kostikas K, et al. Involvement of lymphatic metastatic spread in non-small cell lung cancer accordingly to the primary cancer location. Lung Cancer, 2004, 44 : 183-191.
  • 6Keller SM, Vangel MG, Wagner H, et al. Prolonged survival in patients with resected non-small cell lung cancer and single-level N2 disease. J Thorac Cardiovasc Surg, 2004, 128 : 130-137.
  • 7Riquet M, Perrotin C, Lang-Lazdunski L, et al. Do patients with adenosquamous carcinoma of the lung need a more aggressive approach? J Thorac Cardiovasc Surg, 2001, 122:618-619.
  • 8王思愚,吴一龙,区伟,杨学宁.非小细胞肺癌纵隔淋巴结跳跃性转移的研究[J].中华肿瘤杂志,2001,23(3):259-261. 被引量:29
  • 9Inoue M, Sawabata N, Takeda S, et al. Results of surgical imervention for p-stage III A (N2) non-small cell lung cancer: acceptable prognosis predicted by complete resection in patients with single N2 disease with primary tumor in the upper lobe. J Thorac Cardiovasc Surg, 2004, 127 : 1100-1106.
  • 10石远凯.美国国家癌症综合网非小细胞肺癌治疗指南2008年第二版介绍[J].中华肿瘤杂志,2008,30(5):397-400. 被引量:20

二级参考文献2

共引文献47

同被引文献33

  • 1李鉴,张德超,赫捷,刘向阳,牟巨伟,张良泽.肺腺鳞癌临床病理特点和外科治疗预后研究[J].中国现代手术学杂志,2009,13(4):241-244. 被引量:4
  • 2Shelton DA, Rana DN, Holbrook M, et al. Adenosquamous carci- noma of the lung diagnosed by cytology? A diagnostic dilenmaa[J]. Diagn Cytopathol, 2 011.[Epub ahead of print].
  • 3Maeda H, Matsumura A, Kawabata T, et al. Adenosquamous carci- noma of the lung: surgical results as compared with squamous cell and adenocarcinoma cases[J].EurJ Gardiothorac Surg, 2012, 41(2): 357-361.
  • 4Nakagawa K, Yasumitu T, Fukuhara K, et al. Poor prognosis after lung resection for patients with adenosquamous carcinoma of the lung[J]. Ann Thorac Surg, 2003, 75(6):1740-1744.
  • 5Shundo Y, Takahashi T, Itaya T, et al. Clinical study of forty-two patients who underwent resection for pulmonary adenosquamous carcinoma[J]. Kyobu Geka, 2011, 64(10):871-876.
  • 6Douillard JY, Rosell R, De Lena M, et al. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resect- ed stage I B-Ⅲ A non-small-cell lung cancer (Adjuvant Navel- bine International Trialist Association [ANITA]) a randomised con- trolled triM[J]. Lancet Oncol, 2006, 7(10):797.
  • 7Suehisa H, Toyooka S. Adjuvant chemotherapy for completely re- sected non-small-cell lung cancer[J].Acta Med Okayama, 2009,63 (5) :223-230.
  • 8Gawrychowski J, Brulinski K, Malinowski E, et al. Prognosis and survival after radical resection of primary adenosquamous lung car- cinoma[J]. EurJ Cardiothorac Surg, 2005, 27(4):686-692.
  • 9Filosso PL, Ruff.aft E, Asioli S, et al. Adenosquarnous lung carcino- mas: a histologic subtype with poor prognosis[J]. Lung Cancer, 2011, 74(1):25-29.
  • 10DouiUardJY, Rosen R, De Lena M,et al.Impact of Postoperative Ra- diationTherapy on Survival in Patients With Complete Resection and Stage ⅠⅡ, or m A Non-Small-Cell Lung Cancer Treated With Adjuvant Chemotherapy:The Adjuvant Navelbine Interna- tional Trialist Association (ANITA) Randomized Trial[J]. IntJ Radi- at Oncol Biol Phys, 2008, 72(3):695-701.

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部